News
Milestone weekend set as Thryv / Race for a Cure team returns
This Easter weekend, Team Thryv | Race For A Cure will return to Mount Panorama with fresh fire in the tank, bringing its 2026 Bathurst campaign to life with Thryv and putting fundraising firmly in the driver’s seat.
The partnership will hit the track at the Bathurst 6 Hour from 3 to 5 April, where Team Thryv | Race For A Cure’s race-prepared BMW M2, car number 92, will take to the circuit in its signature orange livery. Supercars star Thomas Randle will lead the driver line-up alongside Ben and Michael Kavich. It marks a high-profile moment for fundraising and awareness, helping drive support for Breast Cancer Trials while carrying one family’s deeply personal mission onto one of Australian motorsport’s biggest stages.
Race For A Cure was born from lived experience. After Toula Kavich was diagnosed with breast cancer following the inaugural Bathurst 6 Hour in 2016, the Kavich family made a choice that would reshape their involvement in the sport. Ben and Michael Kavich turned their passion for racing into a platform for purpose, building a fundraising movement that has already raised more than $266,000 for Breast Cancer Trials.
Having also faced cancer himself, Thomas brings both elite racing credentials and lived understanding to the Race For A Cure mission, making his involvement especially meaningful on one of Australian motorsport’s biggest stages.
Now, with Thryv again backing the team, the 2026 Bathurst effort is aiming to go further, raise more and bring even more people behind the cause.
Team Thryv | Race For A Cure, Driver, Ben Kavich, said, “Race For A Cure has always come from the heart. What started as something deeply personal for our family has grown into a platform that lets us give back in a meaningful way and keep pushing for better outcomes for others facing breast cancer.”
“The Bathurst 6 Hour is one of the biggest stages in Australian motorsport and an amazing opportunity to shine a light on this very important cause, rally support and keep building momentum.
“There is a real connection between racing and small business. In both, you need determination, resilience and people around you who believe in what you are doing. That is why this partnership feels so genuine. We are proud to have Thryv alongside us again.
“We are also excited about what is ahead with Thryv, with some significant announcements to come in the months ahead, so stay tuned!” said Ben.
Elise Balsillie, Head of Thryv Australia and New Zealand, said, “Small business owners know what it means to operate under pressure. They make decisions on the run, adapt quickly, back their people and keep showing up with purpose. That same determination is what you see in endurance racing, and it is a big part of why this partnership resonates so strongly.”
“Ben, Michael and Toula have created something incredibly powerful through Race For A Cure. They have taken a personal experience and turned it into action, awareness and real fundraising impact. We are proud to stand with them and help amplify that mission.
“This partnership is not only full of heart, but also of intent. We want to use the visibility of motorsport to help drive awareness, spark conversations and encourage more support for the research that changes lives,” said Elise.
“Every significant advancement in breast cancer treatment has been achieved through clinical trials research, so the support of the Kavich family over the past decade, along with Thryv’s vehicle sponsorship, means so much,” said Karen Price, CEO, Breast Cancer Trials.
“That’s 10 years of fuelling new and better treatments, 10 years of improving prevention strategies and 10 years of helping save lives.”
According to Toula Kavich, the 2026 Bathurst campaign is a deeply emotional milestone, arriving almost 10 years after the diagnosis that changed the course of her family’s life.
“When I was diagnosed with breast cancer a decade ago, it was one of the hardest periods our family had ever faced. There was fear, uncertainty and a long journey ahead, and at the time, you are simply trying to get through each day as best you can.
“That is why this means so much. To see something so personal grow into a platform that is helping others and supporting vital research is incredibly powerful.
“I am so proud of what Ben and Michael have built through Race For A Cure, and so grateful to everyone who has stood behind it. It is deeply emotional to know that from something so difficult, something meaningful and lasting can grow,” Toula said.
The Bathurst 6 Hour marks the start of what promises to be a powerful Easter weekend for Team Thryv | Race For A Cure, with the campaign set to build visibility for the cause and encourage support well beyond race weekend.
The 2026 Bathurst 6 Hour will take place over the Easter long weekend. If you are interested in donating to Race For A Cure, visit www.raceforacure.org.au
ABOUT THRYV
Thryv (NASDAQ: THRY) is an AI-enabled global marketing platform that helps small businesses (SMBs) get found online faster, win more customers, and drive repeat business. Thryv software offers SMBs AI-driven lead insights, automated customer follow‑up and payment processing, an AI-enabled CRM and a suite of additional solutions. Thryv is making growth‑focused AI tools accessible to the plumber, salon owner, contractor, lawyer, accountant and more. Over 200K+ businesses globally use Thryv to market, sell, and grow. For more information, visit www.thryv.com.
ABOUT BREAST CANCER TRIALS
Breast Cancer Trials (BCT) is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand, all dedicated to exploring and finding better treatments for people who are affected by breast cancer.
Founded in 1978, BCT conducts a multi-centre national and international clinical trials research program, involving more than 1,000 researchers in 118 institutions across Australia and New Zealand. More than 17,910 people have participated in 95 clinical trials, including those who have been directly involved with the research.
Breast Cancer Trials’ unique collaboration between researchers, clinical trial participants and supporters has led to improvements in breast cancer treatment, changes in management strategies, and ultimately, saved millions of lives.
The belief that drives this effort is simple: New and better treatments and prevention strategies will be found – ones that will help see a world where no more lives are cut short. https://www.breastcancertrials.org.au/